Reported Standalone quarterly numbers for Indo US Bio-Tech are:
Net Sales at Rs 30.77 crore in June 2025 up 24.48% from Rs. 24.72 crore in June 2024.
Story continues below Advertisement
Quarterly Net Profit at Rs. 4.70 crore in June 2025 up 48.41% from Rs. 3.17 crore in June 2024.
EBITDA stands at Rs. 5.47 crore in June 2025 up 47.04% from Rs. 3.72 crore in June 2024.
Indo US Bio-Tec EPS has increased to Rs. 2.35 in June 2025 from Rs. 1.58 in June 2024.
Story continues below Advertisement
Indo US Bio-Tec shares closed at 147.92 on September 04, 2025 (NSE) and has given -22.10% returns over the last 6 months and -49.45% over the last 12 months.
| Indo US Bio-Tech | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'25 | Mar'25 | Jun'24 | | Net Sales/Income from operations | 30.77 | 33.38 | 24.72 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 30.77 | 33.38 | 24.72 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | 7.15 | 20.08 | 0.13 | | Increase/Decrease in Stocks | 6.13 | -26.50 | 5.30 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.32 | 0.34 | 0.29 | | Depreciation | 0.20 | 0.56 | 0.20 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 11.70 | 34.88 | 15.31 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 5.27 | 4.02 | 3.49 | | Other Income | 0.00 | 0.12 | 0.03 | | P/L Before Int., Excpt. Items & Tax | 5.27 | 4.14 | 3.52 | | Interest | 0.45 | 0.26 | 0.33 | | P/L Before Exceptional Items & Tax | 4.82 | 3.88 | 3.19 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 4.82 | 3.88 | 3.19 | | Tax | 0.12 | 0.19 | 0.02 | | P/L After Tax from Ordinary Activities | 4.70 | 3.68 | 3.17 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 4.70 | 3.68 | 3.17 | | Equity Share Capital | 20.05 | 20.05 | 20.05 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 2.35 | 1.86 | 1.58 | | Diluted EPS | 2.35 | 1.86 | 1.58 | | EPS After Extra Ordinary | | Basic EPS | 2.35 | 1.86 | 1.58 | | Diluted EPS | 2.35 | 1.86 | 1.58 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
